Bridging a Patient with Acute Liver Failure to Liver Transplantation by the AMC-Bioartificial Liver
| Autor: | Maarten-Paul Van De Kerkhove, Ernesto Di Florio, Vincenzo Scuderi, Antonio Mancini, Antonello Belli, Adele Bracco, Daniela Scala, Simona Scala, Laura Zeuli, Giuseppe Di Nicuolo, Pietro Amoroso, Fulvio Calise, Robert A. F. M. Chamuleau |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2003 |
| Předmět: | |
| Zdroj: | Cell Transplantation, Vol 12 (2003) |
| Druh dokumentu: | article |
| ISSN: | 0963-6897 1555-3892 00000000 |
| DOI: | 10.3727/000000003108747163 |
| Popis: | Recently a phase I clinical trial has been started in Italy to bridge patients with acute liver failure (ALF) to orthotopic liver transplantation (OLT) by the AMC-bioartificial liver (AMC-BAL). The AMC-BAL is charged with 10 × 109 viable primary porcine hepatocytes isolated from a specified pathogen-free (SPF) pig. Here we report a patient with ALF due to acute HBV infection. This patient was treated for 35 h by two AMC-BAL treatments and was bridged to OLT. There was improvement of biochemical and clinical parameters during the treatment. No severe adverse events were observed during treatment and follow-up of 15 months after hospital discharge. Possible porcine endogenous retrovirus (PERV) activity could not be detected in the patient's blood or blood cells up to 12 months after treatment. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|